The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Tapia Abellán, Ana ^a   Martínez Esparza, María ^a   Ruiz Alcaraz, Antonio J ^a   Hernández Caselles, Trinidad ^a   Martínez Pascual, Cristina ^b   Miras López, Manuel ^b   Such, José ^c,d   Francés, Rubén ^c,d   García Peñarrubia, Pilar ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Alcohol; Ascites; Cirrhosis; Cytokines; Etiology; HCV; MAP kinases

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; BACTERIAL TRANSLOCATION; BLOOD CELL; CELL POPULATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE MIGRATION; LIVER BIOPSY; LIVER CIRRHOSIS; MACROPHAGE; MALE; MONOCYTE; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; POLYMORPHONUCLEAR CELL; T LYMPHOCYTE;

ASCITES; CELL SEPARATION; CYTOKINES; FEMALE; HEPATITIS C; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; LIVER CIRRHOSIS, ALCOHOLIC; MACROPHAGES, PERITONEAL; MALE; MIDDLE AGED; MONOCYTES; PHOSPHORYLATION;

EID: 84864507500     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-42     Document Type: Article

References (32)

1. Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 2010, 16:287-297. 2896468, 20386865.
2. Chen CM, Yoon YH, Yi HY, Lucas DL. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res 2007, 31:285-292. 10.1111/j.1530-0277.2006.00304.x, 17250621.
3. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008, 47:1128-1135.
4. Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995, 15:300-306.
5. Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, Boix L, et al. Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J 2006, 3:98. 10.1186/1743-422X-3-98, 1676004, 17121680.
6. Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B. Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res 2011, 35:787-793. 10.1111/j.1530-0277.2010.01399.x, 3083482, 21284667.
7. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004, 287:G497-G502. 10.1152/ajpgi.00171.2004, 15331349.
8. Heller J, Sogni P, Barriere E, Tazi KA, Chauvelot-Moachon L, Guimont MC, et al. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 2000, 33:376-381. 10.1016/S0168-8278(00)80272-X, 11019992.
9. Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S, et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004, 53:860-864. 10.1136/gut.2003.027425, 1774083, 15138214.
10. Ruiz-Alcaraz AJ, Martinez-Esparza M, Cano R, Hernandez-Caselles T, Recarti C, Llanos L, et al. Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion. Eur J Clin Invest 2011, 41:8-15. 10.1111/j.1365-2362.2010.02368.x, 20731703.
11. Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, Cipriano V, et al. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Dig Liver Dis 2011, 43:807-813. 10.1016/j.dld.2011.04.020, 21684822.
12. Li WY, Jiang YF, Jin QL, Zhang H, Feng XW, Niu JQ. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol 2010, 201:138237.
13. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009, 49:646-657. 10.1002/hep.22680, 19177575.
14. Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL. Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol Dietol 2007, 53:1-7.
15. Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernandez-Varo G, Held KF, et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut 2012, in press. doi: gutjnl-2011-300703.
16. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010, 5:e11049. 10.1371/journal.pone.0011049, 2883575, 20548789.
17. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 2011, 6:e21381. 10.1371/journal.pone.0021381, 3120868, 21731723.
18. Delhem N, Cottrez F, Carpentier A, Miroux C, Morales O, Francois V, et al. Role of the regulatory T lymphocytes in hepatitis C fibrosis progression. Bull Cancer 2008, 95:1029-1038.
19. Osna NA. Hepatitis C virus and ethanol alter antigen presentation in liver cells. World J Gastroenterol 2009, 15:1201-1208. 10.3748/wjg.15.1201, 2658850, 19291820.
20. Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol 2003, 64:224-230. 10.1016/S0198-8859(02)00781-4, 12559624.
21. Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ, et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 2007, 46:816-826. 10.1016/j.jhep.2006.12.018, 17328986.
22. Dolganiuc A, Garcia C, Kodys K, Szabo G. Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 2006, 12:1198-1204.
23. Mozer-Lisewska I, Sluzewski W, Kaczmarek M, Jenek R, Szczepanski M, Figlerowicz M, et al. Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol 2005, 62:407-412. 10.1111/j.1365-3083.2005.01670.x, 16253129.
24. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-335. 10.1002/hep.22306, 18506843.
25. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998, 27:669-674. 10.1086/514940, 9798013.
26. Albillos A, Cuervas-Mons V, Millan I, Canton T, Montes J, Barrios C, et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology 1990, 98:134-140.
27. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123. 10.1001/jama.1995.03520260039030, 7799491.
28. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699. 10.1056/NEJM199603143341104, 8594428.
29. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med 1986, 146:2259-2261. 10.1001/archinte.1986.00360230201029, 2946271.
30. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 1988, 95:1351-1355.
31. Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C, et al. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology 2009, 137:1669-1679. 10.1053/j.gastro.2009.07.058, 19660462.
32. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010, 40:35-53. 10.1111/j.1365-2362.2009.02234.x, 20055895.